TNA Therapeutics Inc. — Form D
TNA Therapeutics Inc. of Ridgewood, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-28. The offering totals $1.6M. Industry: Biotechnology.
Offering
- Filed: 2022-03-28
- Form: D
- Accession: 0001919837-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Remaining: $1.6M
- Minimum investment: $25K
- Revenue range: No Revenues
- SEC file number: 021-439121
Issuer
- Name: TNA Therapeutics Inc.
- CIK: 0001919837
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 33 Bryden Place, Ridgewood, NJ, 07450
- Phone: 201-994-9936
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Nicholas Puro | Director | Portland, OR |
| Thomas J Knapp | Executive Officer | Bethesda, MD |
| Luke Piggott | Executive Officer | Pully, V8 |
More